Target Gene/Pathway💬 Info on mouse-over

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	Disease ID
1	Aldosterone synthesis and secretion 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D01303 💬	Flunarizine	[4] 58, 86, 149, 215 💬
2	Aldosterone synthesis and secretion 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	[4] 58, 86, 149, 215 💬
3	Calcium signaling pathway 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D01303 💬	Flunarizine	[4] 58, 86, 149, 215 💬
4	Calcium signaling pathway 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	[4] 58, 86, 149, 215 💬
5	cAMP signaling pathway 💬	[2] GABBR1, GABBR2 💬	D00241 💬	Baclofen	[5]  2 , 10, 13, 18, 149 💬
6	Circadian entrainment 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D01303 💬	Flunarizine	[4] 58, 86, 149, 215 💬
7	Circadian entrainment 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	[4] 58, 86, 149, 215 💬
8	Circadian entrainment 💬	[2] MTNR1A, MTNR1B 💬	D08170 💬	Melatonin	[11]  6 ,  8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
9	Cortisol synthesis and secretion 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D01303 💬	Flunarizine	[4] 58, 86, 149, 215 💬
10	Cortisol synthesis and secretion 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	[4] 58, 86, 149, 215 💬
11	Cushing syndrome 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D01303 💬	Flunarizine	[4] 58, 86, 149, 215 💬
12	Cushing syndrome 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	[4] 58, 86, 149, 215 💬
13	ECM-receptor interaction 💬	[1] SV2A 💬	D08879 💬	Brivaracetam	[2] 149, 309 💬
14	ECM-receptor interaction 💬	[3] SV2A, SV2B, SV2C 💬	D11842 💬	Padsevonil	[1] 149 💬
15	Estrogen signaling pathway 💬	[2] GABBR1, GABBR2 💬	D00241 💬	Baclofen	[5]  2 , 10, 13, 18, 149 💬
16	GABAergic synapse 💬	[2] GABBR1, GABBR2 💬	D00241 💬	Baclofen	[5]  2 , 10, 13, 18, 149 💬
17	GnRH secretion 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D01303 💬	Flunarizine	[4] 58, 86, 149, 215 💬
18	GnRH secretion 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	[4] 58, 86, 149, 215 💬
19	GnRH secretion 💬	[2] GABBR1, GABBR2 💬	D00241 💬	Baclofen	[5]  2 , 10, 13, 18, 149 💬
20	Insulin secretion 💬	[1] SNAP25 💬	D00783 💬	Botulinum toxin type A	[13]  2 ,  5 ,  6 ,  7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬
21	MAPK signaling pathway 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D01303 💬	Flunarizine	[4] 58, 86, 149, 215 💬
22	MAPK signaling pathway 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D07971 💬	Flunarizine	[4] 58, 86, 149, 215 💬
23	Morphine addiction 💬	[2] GABBR1, GABBR2 💬	D00241 💬	Baclofen	[5]  2 , 10, 13, 18, 149 💬
24	Neuroactive ligand-receptor interaction 💬	[2] GABBR1, GABBR2 💬	D00241 💬	Baclofen	[5]  2 , 10, 13, 18, 149 💬
25	Neuroactive ligand-receptor interaction 💬	[2] MTNR1A, MTNR1B 💬	D08170 💬	Melatonin	[11]  6 ,  8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
26	Synaptic vesicle cycle 💬	[1] SNAP25 💬	D00783 💬	Botulinum toxin type A	[13]  2 ,  5 ,  6 ,  7 , 13, 15, 17, 36, 51, 70, 113, 149, 226 💬
27	Taste transduction 💬	[2] GABBR1, GABBR2 💬	D00241 💬	Baclofen	[5]  2 , 10, 13, 18, 149 💬
28	Taste transduction 💬	[2] SCN3A, SCN9A 💬	D07299 💬	Lacosamide	[3]  2 , 46, 149 💬
29	Type II diabetes mellitus 💬	[1] CACNA1G 💬	D01303 💬	Flunarizine	[4] 58, 86, 149, 215 💬
30	Type II diabetes mellitus 💬	[1] CACNA1G 💬	D07971 💬	Flunarizine	[4] 58, 86, 149, 215 💬

Back to top